TCF National Bank »

Regeneron Pharmaceuticals shares owned by TCF National Bank

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by TCF National Bank from 13F filings

Historical chart of TCF National Bank investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by TCF National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by TCF National Bank

Quarter filed Position value Share count Share price at filing
2021-03-31 $456k 964 473.03
2020-12-31 $384k 794 483.63
2020-09-30 $314k 561 559.71

More positions owned by TCF National Bank

Tcf Financial Corp Common Stock
Apple Common Stock (AAPL)
Dow Common Stock (DOW)
Microsoft Corp Common Stock (MSFT)
Dupont De Nemours Common Stock (DD)
Johnson Johnson Common Stock (JNJ)
Jp Morgan Chase Common Stock (JPM)
Amazon.com Common Stock (AMZN)
Alphabet Inc Cl A Common Stock (GOOGL)
Corteva Common Stock (CTVA)
Spdr Sp 500 Etf Trust Other (SPY)
Abbott Labs Common Stock (ABT)
Vanguard Short Term Corp Bond Other (VCSH)
Intel Corp Common Stock (INTC)
Vanguard Ind Fd Mid-cap Other (VO)

View all positions for TCF National Bank

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
T. Rowe Price Associates
Loomis, Sayles and
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals